— Know what they know.
Not Investment Advice
Also trades as: VIV.V (TSXV) · $vol 0M

VIVXF OTC

Avivagen Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $7769 mcap · 77M float · 0.0002% daily turnover

Balance Sheet Trends

Total Assets
$1M -60.7% ▼
5Y CAGR: -5.9%
Total Liabilities
$7M -1.1% ▼
5Y CAGR: +34.3%
Shareholders Equity
-$6M -51.4% ▼
Cash & Investments
$290K -79.4% ▼
5Y CAGR: -28.9%
Total Debt
$6M -10.6% ▼
5Y CAGR: +43.6%
Net Debt
$6M +7.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$2M$1M$664K$1M$290K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$1M$664K$1M$290K
Net Receivables$227K$133K$527K$343K$573K
Inventory$579K$452K$406K$1M$314K
Other Current Assets$0$0$84K$125K$26K
Total Current Assets$3M$2M$2M$3M$1M
Property, Plant & Equip.$67K$172K$394K$262K$94K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$67K$172K$394K$262K$94K
Total Assets$3M$2M$2M$3M$1M
— Liabilities —
Accounts Payable$698K$511K$710K$463K$911K
Short-Term Debt$247K$746K$2M$5M$810K
Deferred Revenue-$42K-$53K$78K$97K$0
Other Current Liabilities$65K$98K$200K$138K$353K
Total Current Liabilities$1M$1M$2M$6M$2M
Long-Term Debt$2M$4M$5M$1M$5M
Other Non-Current Liab.$0$0$0-$20K$0
Total Non-Current Liabilities$2M$4M$5M$1M$5M
Total Liabilities$3M$5M$7M$7M$7M
— Equity —
Common Stock$23M$24M$27M$32M$35M
Retained Earnings-$26M-$31M-$35M-$40M-$45M
Accumulated OCI$250K$350K$0$0$0
Total Stockholders Equity$94K-$3M-$5M-$4M-$6M
Total Liabilities & Equity$3M$2M$2M$3M$1M
— Key Metrics —
Total Debt$2M$5M$6M$7M$6M
Net Debt$45K$4M$5M$5M$6M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms